ライフサイエンスコーパス: xenon

1 eparation of rare gases, such as krypton and xenon.

2 xenon, in addition to chondritic (or solar) xenon.

3 rmia (33.5 degrees C) + 24 hours 50% inhaled xenon.

4 ed at 2.5-4.5 eV, compared to 6.7-8.7 eV for xenon.

5 ing it into inert gas atoms such as argon or xenon.

6 d identify SBMOF-1 as the most selective for xenon.

7 M = Ca, Sr, Ba) containing framework-forming xenon.

8 nt (ADC) values obtained with hyperpolarized xenon 129 ((129)Xe) magnetic resonance (MR) imaging to q

9 nce (MR) imaging with inhaled hyperpolarized xenon 129 ((129)Xe).

10 mporary encapsulation of spin-hyperpolarized xenon ((129)Xe) atoms in cryptophane-A-monoacid (CrAma)

11 e low ratios of radiogenic to non-radiogenic xenon ((129)Xe/(130)Xe) in ocean island basalts (OIBs) c

12 and negligible reactivity of hyperpolarized xenon-129 (HP(129)Xe) make it attractive for a number of

13 Studies of hyperpolarized xenon-129 (hp-(129)Xe) in media such as liquid crystals

14 ical pumping (SEOP) and hyperpolarization of xenon-129 gas.

15 increase the sensitivity of a hyperpolarized xenon-129 MRI contrast agent.

16 Here we present a "smart" xenon-129 NMR biosensor that undergoes a peptide conform

17 acilitated by continuous flow hyperpolarized xenon-129 two-dimensional exchange NMR spectroscopy.

18 Studies using xenon-133 show Zone 4 behaviour, present in the dependen

19 Mass spectra for xenon, 2-chloroethyl ethyl sulfide (CEES), and octane we

20 mia; (2) normothermia + 24 hours 50% inhaled xenon; (3) 24 hours hypothermia (33.5 degrees C); or (4)

21 se were randomized to receive either inhaled xenon (40% end-tidal concentration) combined with hypoth

22 pectral peaks was found to increase 143% for xenon, 40% for CEES, and 77% for octane over this pressu

23 Seventy-five percent xenon, 50% xenon, or 30% xenon, with 25% oxygen (balance

24 or 16 hrs) or mild therapeutic hypothermia 1 xenon (70% for 1 hr).

25 Utilizing X-ray crystallography with xenon, a tunnel network has been shown to serve as a mol

26 tion transfer between GV-bound and dissolved xenon-a technique currently implemented in vitro.

27 that preconditioning with the anesthetic gas xenon activates hypoxia-inducible factor 1alpha (HIF-1al

28 n Norway to Lewis rat renal transplantation, xenon administered to donor or recipient decreased the r

29 SBMOF-1 exhibits by far the highest reported xenon adsorption capacity and a remarkable Xe/Kr selecti

30 ability is attributable not only to the high xenon affinity and cage-like nature of the host, but als

31 This value represents the highest measured xenon affinity for a host molecule.

32 afforded by detection of the bulk dissolved xenon allows sensitive detection of targets.

33 ss clinical outcomes associated with inhaled xenon among survivors of out-of-hospital cardiac arrest.

34 Xenon anaesthesia has recently been evaluated in large-s

35 Despite the relatively high cost of xenon anaesthesia, xenon has clear clinical advantages o

36 ime at which the neuroprotective noble gases xenon and argon should be administered, during or after

37 erent noble-gas-element bonds is limited for xenon and even more so for krypton.

38 monstrated the ability to selectively adsorb xenon and krypton at ambient conditions.

39 spontaneously binds to the noble gases (Ngs) xenon and krypton at room temperature in a reaction that

40 ures, and thermal stabilities of a series of xenon and krypton clathrates of (+/-)-cryptophane-111 (1

41 he release of volatile radionuclides such as xenon and krypton that evolve into reprocessing facility

42 solution) in the presence of high-brightness xenon and mercury vapor light sources.

43 vestigate a possible direct reaction between xenon and oxygen at high pressures.

44 cal potential for the separation of krypton, xenon and radon from air at concentrations of only a few

45 Xenon and radon have many similar properties, a differen

46 dicated static quenching by the encapsulated xenon and the presence of a second non-xenon-binding con

47 as calf muscle blood flow (CalfBF, (1)(3)(3)xenon) and calf vascular conductance (CalfVC) were measu

48 In contrast, nitrous oxide, xenon, and ketamine produce analgesia, but weak hypnosis

49 nsciousness during anesthesia with propofol, xenon, and ketamine, independent of behavioral responsiv

50 rtical activation with low complexity during xenon anesthesia, and a wakefulness-like, complex spatio

51 experience after emergence from propofol and xenon anesthesia, whereas after ketamine they reported l

52 In this model, xenon application has a therapeutic time window of up to

53 ells using standard fluorescent proteins and xenon arc lamp illumination.

54 e floating zone technique using a high power xenon arc lamp image furnace.

55 ene, 2-methylpropene, and 1,3-butadiene even xenon are coencapsulated with other guests and their mot

56 The inert gases helium and xenon are effective neuroprotectants in a model for trau

57 NETD of GAGs, using fluoranthene or xenon as the reagent gas, produces fragmentation very si

58 Xenon associated with the target-bound cryptophane cage

59 y and fluorescence quenching assay to have a xenon association constant of 33,000 M(-1) at 293 K, whi

60 The cryptophane-xenon association constant, K(a)=42,000 +/- 2,000 M(-1)

61 attice to the distances observed in metallic xenon at megabar pressures.

62 solvent), is exceptionally stable, retaining xenon at temperatures of up to about 300 degrees C.

63 bonic anhydrase II shows how an encapsulated xenon atom can be directed to a specific biological targ

64 ally inert tip whose apex is terminated by a xenon atom cannot induce the reaction because of a weak

65 e is temperature dependent, meaning that the xenon atom changes both DeltaH and DeltaS for the reacti

66 ht-bond-linked biosensor containing a single xenon atom in the CAII active site.

67 s of the peak heights show that the included xenon atom substantially changes the equilibrium constan

68 Xenon atoms adopt mixed oxidation states of 0 and +4 in

69 The positive regions of the terminal xenon atoms and associated fluorine bridge bonds corresp

70 However, it is possible that xenon atoms may be retained at defects in mantle silicat

71 hat is fluorine bridged through its terminal xenon atoms to two [mu-F(ReO2F3)2](-) anions.

72 by the exposed core charges of the terminal xenon atoms.

73 Xenon-augmented hypothermia also reduced transferase-med

74 Compared with hypothermia, xenon-augmented hypothermia did not reach statistical si

75 Compared with no treatment, xenon-augmented hypothermia reduced cerebral MRS abnorma

76 ); for lactate/N-acetylaspartate (NAA), only xenon-augmented hypothermia reduced the slope (p < 0.01)

77 d with no intervention, both hypothermia and xenon-augmented hypothermia reduced the temporal regress

78 Xenon-based molecular sensors are molecular imaging agen

79 cer of HIF-1alpha and that administration of xenon before renal ischemia can prevent acute renal fail

80 on the reversible exchange of hyperpolarized xenon between the bulk and a specifically targeted host-

81 nvestigate this sensitivity enhancement, the xenon binding kinetics of TAAC in water was studied by N

82 leA substrates, in conjunction with a single xenon binding site, leads to the putative assignment of

83 necting the C- and A-clusters, with 17 of 19 xenon binding sites within the predicted regions.

84 The known xenon-binding (+/-)-cryptophane-111 (1) has been functio

85 lated xenon and the presence of a second non-xenon-binding conformer in solution.

86 The sensor comprises a xenon-binding cryptophane cage, a target interaction ele

87 A xenon-binding cryptophane was substituted with linkers o

88 e NMR chemical shift range made available by xenon-binding molecular hosts.

89 as a single-binding-site enzyme for studying xenon biosensor-protein interactions.

90 Thus, xenon biosensors may provide a powerful strategy for dia

91 Coupled with targeted xenon biosensors, Hyper-SAGE offers another path to high

92 latforms ready to use for the preparation of xenon biosensors.

93 Using fluoranthene or xenon, both glycosidic and cross-ring cleavages are obse

94 erpolarized nuclei, such as in the noble gas xenon, but previous reporters acting on such nuclei have

95 nhancing the sensitivity of NMR of dissolved xenon by detecting the signal after extraction to the ga

96 ia group, n=18) alone or in combination with xenon by inhalation, to achieve a target concentration o

97 The fact that xenon can be incorporated into the perovskite structure

98 Xenon chemical exchange saturation transfer (CEST) inter

99 ic binding of a small molecule can produce a xenon chemical shift change, suggesting a general approa

100 Here we present xenon chloride excimer laser-induced melt-mediated phase

101 pted with a laser sheath powered by a 308-nm xenon chloride excimer laser.

102 observing characteristic Bragg patterns from xenon clusters trapped in the vortex cores.

103 In xenon clusters, photo- and Auger electrons contribute mo

104 randomly assigned to receive either inhaled xenon combined with hypothermia (33 degrees C) for 24 ho

105 The authors previously reported that inhaled xenon combined with hypothermia attenuates brain white m

106 s of out-of-hospital cardiac arrest, inhaled xenon combined with hypothermia compared with hypothermi

107 n comparison with hypothermia alone, inhaled xenon combined with hypothermia suggested a less severe

108 However, xenon compounds cannot exist in the Earth's mantle: xeno

109 e the key factors favouring the formation of xenon compounds.

110 The median end-tidal xenon concentration was 47% and duration of the xenon in

111 esthetic agents, specifically isoflurane and xenon, consistent long-term protection by either agent h

112 olid hydrogen lattice modulated by layers of xenon, consisting of xenon dimers.

113 oxidase crystal structures in the absence of xenon correspond well with later experimentally observed

114 Other methods, like perfusion CT, xenon CT, MR spectroscopy, diffusion weighted MRI and fu

115 hemical reactions that could account for the xenon deficiency relative to argon observed in terrestri

116 After extraction the xenon density can be further increased by several orders

117 e determined, along with inhibitor-bound and xenon-derivatized structures, to improve our understandi

118 In addition, xenon did not induce significant conduction, repolarizat

119 noscale vent holes on each chip by gas-phase Xenon difluoride etching.

120 modulated by layers of xenon, consisting of xenon dimers.

121 perature dependence of the chemical shift of xenon dissolved in adipose tissue to directly measure BA

122 e no unexpected serious adverse reactions to xenon during hospital stay.

123 ts demonstrate that even a short exposure to xenon during induction of mild therapeutic hypothermia r

124 Cryptophanes represent an exciting class of xenon-encapsulating molecules that can be exploited as p

125 ere, we report quantification of BAT mass by xenon-enhanced computed tomography.

126 ies reveal the neuroprotective properties of xenon, especially when combined with hypothermia.

127 ta were modeled numerically to determine the xenon exchange dynamics of the system.

128 spin depolarization to occur, while allowing xenon exchange with the bulk solution during the hyperpo

129 In addition, xenon exerts preconditioning effects in the heart and ma

130 Xenon exposure enhanced the expression of heat-shock pro

131 o-Lewis rat model of kidney transplantation, xenon exposure to donors before graft retrieval or to re

132 We demonstrated that xenon exposure to human proximal tubular cells (HK-2) le

133 mission in a thimble-sized resonator using a xenon flash lamp as an optical pump source with peak opt

134 g submillisecond light pulses generated by a xenon flash lamp.

135 normally require UV-excitation produced by a xenon flash or nitrogen laser light source.

136 DBFI-T were further confirmed by independent Xenon-flash time-resolved microwave conductivity measure

137 The xenon-fluoride bond dissociation energy in XeF3- has bee

138 r to cooling in combination with 30% inhaled xenon for 24 h started immediately after randomisation.

139 gas as a nonperturbing reporting medium, as xenon freely exchanges between aqueous solution and the

140 contrast agent uses dissolved hyperpolarized xenon gas as a nonperturbing reporting medium, as xenon

141 dence from preclinical models indicates that xenon gas can prevent the development of cerebral damage

142 cit, while images in another rat showed that xenon gas exchange was temporarily impaired after saline

143 rovides a valuable complementary tool to the xenon gas method that is used to map nonpolar oxygen-bin

144 ive imaging of BAT in mice by hyperpolarized xenon gas MRI.

145 proposed method images the uptake of inhaled xenon gas to the extravascular brain tissue compartment

146 We assessed whether the addition of xenon gas, a promising novel therapy, after the initiati

147 One example of such a sensing medium is xenon gas, which is chemically inert and can be opticall

148 H. polymorpha amine oxidase in complex with xenon gas, which serves as an experimental probe for mol

149 vivo MR thermometry of BAT by hyperpolarized xenon gas.

150 pecific cell markers by detection of exhaled xenon gas.

151 e was 3.8% higher (95% CI, 1.1%-6.4%) in the xenon group (adjusted mean difference, 0.016 [95% CI, 0.

152 sotropy values were 0.433 (SD, 0.028) in the xenon group and 0.419 (SD, 0.033) in the control group.

153 e, the median (IQR) value was 1 (1-6) in the xenon group and 1 (0-6) in the control group (median dif

154 troponin-T at 72 h was 0.79 +/- 1.54 in the xenon group and 1.56 +/- 1.38 in the control group (adju

155 onth mortality rate was 27.3% (15/55) in the xenon group and 34.5% (19/55) in the control group (adju

156 ooling only group and 41 in the cooling plus xenon group underwent magnetic resonance assessments and

157 period in the mild therapeutic hypothermia 1 xenon group while one animal in each of the other two gr

158 a (33 degrees C) for 24 hours (n = 55 in the xenon group) or hypothermia treatment alone (n = 55 in t

159 hypothermia (33 degrees C) for 24 h (n = 55; xenon group) or hypothermia treatment alone (n = 55; con

160 ants died in the cooling group and 11 in the xenon group.

161 Two adverse events were reported in the xenon group: subcutaneous fat necrosis and transient des

162 Xenon had the most consistent effects, being neuroprotec

163 the ability of these new derivatives to bind xenon has been investigated.

164 The "inert" gas xenon has been shown to be an effective neuroprotectant

165 By comparison, the chemistry of xenon has been widely studied and applied in science and

166 e relatively high cost of xenon anaesthesia, xenon has clear clinical advantages over other current a

167 enal ischemia reperfusion injury; helium and xenon have additionally been tested in hepatic ischemia

168 , sevoflurane, enflurane, nitrous oxide, and xenon, have been demonstrated to trigger widespread neur

169 measured for a high-affinity, water-soluble xenon host molecule near rt.

170 ution, which is the record for a single-unit xenon host.

171 Each xenon(II) atom is surrounded by a torus of xenon valence

172 ation provides an unprecedented example of a xenon(II) oxide and a noble-gas oxocation as well as a r

173 me, peculiarities of electronic structure of xenon impose specific features on the bonding within a p

174 These results show for the first time that xenon improves neurologic outcome and reduces contusion

175 The secondary coordination spheres of xenon in [H5F4][SbF6].2[XeF3.HF][Sb2F11] and [XeF3.HF][S

176 This irreversible insertion and trapping of xenon in Ag-natrolite under moderate conditions sheds ne

177 We detected dissolved xenon in an aqueous liquid crystal that is disrupted by

178 ives, which exhibit exceptional affinity for xenon in aqueous solution.

179 Donors or recipients treated with xenon in combination with cyclosporin A had prolonged re

180 Rosetta spacecraft analyzed the isotopes of xenon in the coma of comet 67P/Churyumov-Gerasimenko.

181 6 metallosupramolecular cage can encapsulate xenon in water with a binding constant of 16 M(-1).

182 [2]Cl(6) exhibits a very high affinity for xenon in water, with a binding constant of 2.9(2) x 10(4

183 Earth atmosphere contains 22 +/- 5% cometary xenon, in addition to chondritic (or solar) xenon.

184 Xenon increased the efficiency of HIF-1alpha translation

185 increase the rotational correlation time of xenon, increasing its relaxation rate.

186 f TAAC in the presence of varying amounts of xenon indicated static quenching by the encapsulated xen

187 Xenon induced cell survival or graft functional recovery

188 on concentration was 47% and duration of the xenon inhalation was 25.5 hours.

189 The 44 subjects tolerated all xenon inhalations, no subjects withdrew, and no serious

190 O8.16H2O (Ag-natrolite) irreversibly inserts xenon into its micropores at 1.7 GPa and 250 degrees C,

191 equilibrium, the concentration of gas-phase xenon is approximately 10 times higher than that of the

192 er oxygen-poor conditions), which shows that xenon is more reactive under pressure than predicted pre

193 In contrast to krypton, xenon is retained within the pores of this zeolite after

194 in the Timmins mine fluids can be linked to xenon isotope changes in the ancient atmosphere and used

195 isotopic composition shows deficits in heavy xenon isotopes and matches that of a primordial atmosphe

196 The xenon isotopic composition shows deficits in heavy xenon

197 The xenon(IV) hydroxide fluoride and oxide fluoride salts, [

198 acetylene/ethylene, linear/branched alkanes, xenon/krypton, etc.

199 was replaced by a fiber optic connected to a xenon lamp and was rapidly scanned over the array.

200 nsity under 100 mW cm(-2) irradiation from a xenon lamp during oxygen evolution without current fadin

201 by chlorophylls irradiated with the use of a xenon lamp equipped with the cut-off 600 nm filter.

202 over a broad range from that of an expanded xenon lattice to the distances observed in metallic xeno

203 ed, which demonstrates that, upon continuous xenon light excitation, rapid decomposition of the HNO d

204 re did not increase RPE toxicity either with xenon light or mercury vapor lamp.

205 easured in Maxwellian view using a broadband xenon light source.

206 combinatorial synthetic approach to produce xenon magnetic resonance sensors that respond to small m

207 clinical setting, then preconditioning with xenon may be beneficial before procedures that temporari

208 These findings support the idea that xenon may be of benefit as a neuroprotective treatment i

209 Administering xenon may confer an additional neuroprotective effect af

210 -T at 72 hours was significantly less in the Xenon+mild therapeutic hypothermia group (p=0.04).

211 e (mild therapeutic hypothermia group, n=17; Xenon+mild therapeutic hypothermia group, n=16).

212 ieve a target concentration of at least 40% (Xenon+mild therapeutic hypothermia group, n=18) for 24 h

213 ild therapeutic hypothermia group=5.30 mg vs Xenon+mild therapeutic hypothermia group=2.95 mg, p=0.06

214 Heart rate was significantly lower in Xenon+mild therapeutic hypothermia patients during hypot

215 but one which can be readily applied as the xenon MRI field moves closer to molecular imaging applic

216 h incorporation of as little as 20 nM of the xenon MRI readout unit, cryptophane-A.

217 They can also be imaged with hyperpolarized xenon MRI using chemical exchange saturation transfer be

218 ates the sensitivity enhancement achieved by xenon MRI.

219 we developed and characterized a functional xenon NMR biosensor that can identify a specific cell su

220 to investigate the renoprotective effect of xenon on early allograft injury associated with prolonge

221 bjective was to assess the effect of inhaled xenon on myocardial ischemic damage in the same study po

222 The effect of xenon on the change in the troponin-T values did not dif

223 n with porphycene and a strong relaxation of xenon on the tip as contact to the molecule is formed.

224 ell up to 40 GPa, was irradiated with 20 GeV xenon or 45 GeV uranium ions, and the (previously unquen

225 s well as in complexes with water, methanol, xenon or chloroform.

226 Seventy-five percent xenon, 50% xenon, or 30% xenon, with 25% oxygen (balance nitrogen)

227 m the recent prediction of Xe3O2 as a stable xenon oxide under high pressure.

228 Other xenon oxides (XeO2, XeO3) are expected to form at higher

229 The possibility of the formation of stable xenon oxides and silicates in the interior of the Earth

230 ompounds cannot exist in the Earth's mantle: xenon oxides are unstable in equilibrium with the metall

231 Earth could explain the atmospheric missing xenon paradox.

232 cluding approximately 74 +/- 7% at 1000 Torr xenon partial pressure, a record value at such high Xe d

233 oponin-T measurements were available from 54 xenon patients and 54 control patients.

234 of K4Xe3O12, the first example of a layered xenon perovskite.

235 le for the detonation sensitivity of layered xenon perovskite.

236 randomly assigned to cooling only and 46 to xenon plus cooling.

237 the strongest known interatomic bonds, while xenon possesses a closed-shell electronic structure: a d

238 These results suggest that xenon preconditioning is a natural inducer of HIF-1alpha

239 ion of BAT thermogenesis, the lipophilic gas xenon preferentially accumulates in BAT, leading to a ra

240 Mild therapeutic hypothermia 1 xenon preserved cardiac output during the induction of m

241 the heme has also been characterized, using xenon pressure on a Ngb mutant (V140W) that binds CO wit

242 e, we report a 2.5 A resolution structure of xenon-pressurized mtCODH/ACS and examine the nature of g

243 Xenon protects allografts against delayed graft function

244 model of renal ischemia-reperfusion injury, xenon provided morphologic and functional renoprotection

245 Xenon-related symptoms were evaluated for relationship t

246 Subjects do experience mild, transient, xenon-related symptoms, consistent with its known anesth

247 Most subjects (91%) did experience transient xenon-related symptoms, most commonly dizziness (59%), p

248 g approach that exploits changes in the bulk xenon relaxation rate induced by slowed tumbling of a cr

249 bination of mild therapeutic hypothermia and xenon resulted in reduced astrogliosis in the CA1 sector

250 flux (up to 200 W at the Rb D1 line) in the xenon-rich regime (up to 1,800 torr Xe in 500 cc) in eit

251 scale clinical trials that have demonstrated xenon's safe and effective clinical profile.

252 Xenon seems to be the only non-transition element which

253 We have incorporated approximately 125 xenon sensor molecules in the interior of an MS2 viral c

254 ting a general approach to the production of xenon sensors targeted to small molecule analytes for in

255 Helium and xenon show organ protective effects mostly in small anim

256 deposits of methanol, water, and methane or xenon show that the presence of methanol accelerates hyd

257 We demonstrate hyperpolarized xenon signal amplification by gas extraction (Hyper-SAGE

258 llic iron occurring in the lower mantle, and xenon silicates are predicted to decompose spontaneously

259 pond well with later experimentally observed xenon sites in these systems, and allow the visualizatio

260 We show that the general anesthetics xenon, sulfur hexafluoride, nitrous oxide, and chlorofor

261 to avidin at 1.5 muM concentration, the free xenon T2 is reduced by a factor of 4.

262 The tendency of high-valence xenon to form consolidated oxide structures is herein su

263 l activity, and the subsequent adsorption of xenon to help identify the nature of those sites.

264 displaying T-shaped primary coordination of xenon to three fluorine atoms (AX3E2 VSEPR arrangement)

265 hobic solutes (methane, ethane, krypton, and xenon) to study hydrophobicity at the most fundamental l

266 Total Body hypothermia plus Xenon (TOBY-Xe) was a proof-of-concept, randomised, open

267 lly, only the mild therapeutic hypothermia 1 xenon-treated animals showed significantly improved neur

268 tor function (p < 0.05) were observed in the xenon-treated group, 1 month after trauma.

269 ores were significantly (p < 0.05) better in xenon-treated groups in the early phase (24 hr) and up t

270 was significantly (p < 0.05) reduced in the xenon-treated groups.

271 repinephrine during hypothermia was lower in xenon-treated patients (mild therapeutic hypothermia gro

272 Our data suggest that xenon treatment attenuates DGF and enhances graft surviv

273 he feasibility and cardiac safety of inhaled xenon treatment combined with therapeutic hypothermia in

274 Our study shows that xenon treatment improves outcome following traumatic bra

275 Xenon treatment in combination with hypothermia is feasi

276 Xenon treatment of graft donors or of recipients prolong

277 Xenon treatment prior to or after hypothermia-hypoxia ch

278 Xenon treatment significantly (p < 0.05) reduced contusi

279 e was significantly (p < 0.05) improved when xenon treatment was given 15 minutes or 1 hour after inj

280 blast infiltration, were also decreased with xenon treatment.

281 We detect a greater than 15-fold increase in xenon uptake by BAT during stimulation of BAT thermogene

282 h xenon(II) atom is surrounded by a torus of xenon valence electron density comprised of the three va

283 Resonant photoionization of atomic xenon was chosen as a case study.

284 tly (p < 0.05) reduced contusion volume when xenon was given 15 minutes after injury or when treatmen

285 Xenon was particularly effective at reducing the seconda

286 re studied in vivo by use of the radioactive xenon washout technique after a hydrocortisone infusion

287 Low pressures of both helium and xenon were effective neuroprotectants when applied in ad

288 change saturation transfer interactions with xenon, which enables chemically amplified GV detection a

289 y exciting is the high-pressure chemistry of xenon, which is known to react with hydrogen and ice at

290 Xenon, which is quite inert under ambient conditions, ma

291 neuroprotective effects of combining inhaled xenon with therapeutic hypothermia after transient cereb

292 eventy-five percent xenon, 50% xenon, or 30% xenon, with 25% oxygen (balance nitrogen) treatment foll

293 accomplished by selectively depolarizing the xenon within a cage molecule which, upon exchange, reduc

294 Administration of xenon within the delayed timeframe used in this trial is

295 Furthermore, xenon works additively with cyclosporin A to preserve po

296 nto four molar contribution factors: natural xenon (Xe nat), natural barium (Ba nat), Ba135, and Ba13

297 Krypton (Kr) and xenon (Xe) adsorption on two partially fluorinated metal

298 Xenon (Xe) is an exceptional tracer for investigating th

299 Studies have demonstrated that xenon (Xe) may have potential as an effective and nontox

300 of a preservative solution supplemented with xenon (Xe), when used on ex vivo kidney grafts in a rat